Priscilla Chan and Mark Zuckerberg pledge $3 billion to fight diseases
After investing millions of dollars in education and opening their own private K-12 school this year, pediatrician Priscilla Chan and her Facebook-founding husband, Mark Zuckerberg, announced Wednesday that they will invest $3 billion over the next decade to fight diseases.
The funds will come from the Chan Zuckerberg Institute, a limited-liability company the couple established last year after the birth of their daughter, with a goal to “advance human potential and promote equality in areas such as health, education, scientific research and energy."
Neuroscientist and geneticist Cori Bargmann was named the Chan Zuckerberg Initiative’s president of science and will be in charge of bringing together scientists and engineers to develop medical breakthroughs.
Chan also announced that the initiative will spend an addition $600 million to establish a “bio hub” in San Francisco to support researchers from Stanford University, UC Berkeley and UC San Francisco as they develop new tools to understand and treat diseases.
After investing millions of dollars in education and opening their own private K-12 school this year, pediatrician Priscilla Chan and her Facebook-founding husband, Mark Zuckerberg, announced Wednesday that they will invest $3 billion over the next decade to fight diseases.
The funds will come from the Chan Zuckerberg Institute, a limited-liability company the couple established last year after the birth of their daughter, with a goal to “advance human potential and promote equality in areas such as health, education, scientific research and energy."
Neuroscientist and geneticist Cori Bargmann was named the Chan Zuckerberg Initiative’s president of science and will be in charge of bringing together scientists and engineers to develop medical breakthroughs.
Chan also announced that the initiative will spend an addition $600 million to establish a “bio hub” in San Francisco to support researchers from Stanford University, UC Berkeley and UC San Francisco as they develop new tools to understand and treat diseases.
